Deep Brain Stimulation for Patients with Treatment-Resistant Obsessive Compulsive Disorder: Identifying electrophysiological biomarkers

Deep Brain Stimulation for Patients with Treatment-Resistant Obsessive Compulsive Disorder: Identifying electrophysiological biomarkers

CONDITION

Mental Health

GENDER

Both males and females

AGE GROUP

18 years to 70 years

TRIAL STATUS

Recruiting

Researchers at QBI are looking for participants diagnosed with treatment-resistant Obsessive-Compulsive Disorder (OCD). If you are you between 18 and 70 years of age and live within reasonable travelling distance to Brisbane, you may be eligible to participate in a study designed to alleviate the symptoms of severe treatment-resistant-OCD through the use of deep brain stimulation.

Deep Brain Stimulation has been successfully used to treat patients with movement disorders but is a relatively new treatment for patients with treatment-resistant Obsessive Compulsive Disorder. This project aims to identify electrical activity in the brain that may guide future management of the severe form of OCD using a brain pacemaker.

Key Inclusion Criteria

We are looking for participants who:

• Have a diagnosis of severe OCD according to the DSM-V criteria
• Score above 24 on the Yale-Brown Obsessive Compulsive Scale
• Have tried the best available medical and psychological treatments for OCD, including:

  • Clomipramine
  • A course of cognitive behavioural therapy (CBT)
  • Reside within reasonable travelling distance of Brisbane

If you are interested in participating in this trial, please contact Lisa McKeown, Clinical Trials Manager: apcn.ocd.trial@uq.edu.au

CONTACT DETAILS

Phone Number: 617 3831 2393
Email: apcn.ocd.trial@uq.edu.au
Location: Asia-Pacific Centre for Neuromodulation The University of Queensland St Andrew’s Place Brisbane QLD 4072

CONTACT SITE

Approved By: Uniting Care Health and The University of Queensland HREC              

Clinical Trial Registry Link: Click Here